Fresenius Group Overview

The Health Care Group
Stories
Archive „Stories“
Investors
Contact

Fresenius SE & Co. KGaA

Investor Relations & Sustainability

+49 (0) 6172 608-2485
ir-fre@fresenius.com
Media
- News
- Social Media
- Calendar
- Contacts
- Media Center
Contact

Matthias Link

Senior Vice President Corporate Communications

T: +49 (0) 6172 608-2872
matthias.link@fresenius.com
Careers
Menu
Filter results
- Chapter
- Format
  - Website (0)
  - PDF (0)
Share
- Facebook
- Twitter
- LinkedIn
- Xing
- E-Mail
Services
- Deutsch
- Print
- Contact
- RSS

Media

Corporate Communications

Here you can find a variety of information:

Our Corporate Communications team can be reached at pr-fre@fresenius.com.

“A pharmacy today? We need to expand it or add something new to it.” (Dr. Eduard Fresenius, Founder, 1912)

LATEST

February 23, 2021 - 01:30 PM | Bad Homburg, Germany

Conference Call Full Year Results 2020, Fresenius

Live Webcast

Live-Webcast Import (ICS) Investor News (PDF) Presentation (PDF) Podcast (MP3) Transcript (PDF)

LATEST
LATEST

February 23, 2021 - 11:00 AM | Bad Homburg, Germany

Press Conference Full Year Results 2020, Fresenius and Fresenius Medical Care

Replay of the Live Webcast

Webcast (Replay) Import (ICS) Press Release Fresenius (PDF) Presentation Fresenius (PDF) Press Release Fresenius Medical Care (PDF) Presentation Fresenius Medical Care (PDF)

LATEST
LATEST

February 20, 2020 - 10:00 AM | Bad Homburg, Germany

Press Conference Full Year Results 2019, Fresenius and Fresenius Medical Care

Webcast replay

Webcast replay Import (ICS) Press Release Fresenius (PDF) Press Release Fresenius Medical Care (PDF) Presentation Fresenius (PDF) Presentation Fresenius Medical Care (PDF)

LATEST

News

Brief News
Fresenius Kabi enters collaboration to enhance the supply of essential medicines for U.S. Patients

Fresenius Kabi has agreed to collaborate with Phlow Corporation, a public benefit company, to expand access to affordable sterile injectables formulated for U.S. children’s hospitals and to help strengthen the supply chain for U.S.-sourced API and essential medicines. The companies will work together to supply private-labelled products, co-develop and manufacture novel products and make essential medicines rapidly available in the event of a public health emergency.

October 14, 2021Fresenius Kabi

Fresenius Medical Care donates 250,000 euros to UNICEF

October 04, 2021Fresenius Medical Care
Fresenius Medical Care publishes 2021 Global Annual Medical Report: Embracing the Complexity of Global Healthcare

September 23, 2021Fresenius Medical Care

Brief News
2022 DRG inflator for German hospitals set at 2.29%

The price increase for hospital services in Germany has been set at 2.29% for 2022. As it is subject to negotiations at the state level as well as individual hospital discounts, the final price increase on the individual hospital level will, however, be lower.

September 15, 2021Fresenius Helios
Fresenius Medical Care celebrates 25th anniversary

September 09, 2021Fresenius Medical Care

Brief News
Fresenius Helios publishes second sustainability report

Helios Germany has published its second sustainability report. The 60 pages report "Strong into the future" looks back on the complex challenges of the Corona year 2020 and shows in which areas the pandemic has driven developments for Germany’s largest private hospital operator. Helios Germany has defined four fields for its sustainability strategy: Patients, employees, the environment and compliance. Like the first report in 2019, it was drawn up based on the GRI standards of the Global Reporting Initiative and is now available in German on www.helios-gesundheit.de/nachhaltigkeit. An English version will be published soon.

September 08, 2021Fresenius Helios
Brief News
Biosimilar candidate of Fresenius Kabi shows positive results in two clinical trials

Fresenius Kabi has reached a milestone on the road to approval for another biosimilar. MSB11456, a tocilizumab biosimilar candidate, successfully met the primary and secondary endpoints in two consecutively conducted clinical trials. For more information, please visit the Fresenius Kabi website.

September 07, 2021Fresenius Kabi

Brief News
Fresenius Helios divests Volkach clinic

Fresenius Helios sells the clinic in Volkach near Würzburg, Germany, to Remedium Healthcare. A corresponding agreement on the 40-bed hospital also includes the transfer of two associated specialist centers in the region. The transaction is a first result of the ongoing strategic review and optimization of Helios' hospital portfolio. The transaction is expected to close by the first quarter of 2022 at the latest. Both sides have agreed not to disclose financial details.

September 07, 2021Fresenius Helios
Brief News
Fresenius Medical Care strengthens transplantation medicine

Fresenius Medical Care expands capabilities at its Global Medical Office: As part of a holistic approach to kidney therapy, the company aims to play an active role in the field of kidney transplantation. To achieve this, Fresenius Medical Care has created the position of Head of Transplantation Medicine and appointed Dr. Benjamin Hippen (49), a US citizen, to fill the post. In this role, he will lead the company’s worldwide efforts to expand access to and understanding of transplant medicine. Dr. Hippen is a distinguished general and transplant nephrologist. He previously served on the Board of Directors of InterWell Health in North America, a nephrology network in which Fresenius Medical Care participates.

September 06, 2021Fresenius Medical Care

Brief News
Helios acquires two hospitals in Kassel, Germany

Helios acquires the DRK (German Red Cross) Kliniken Nordhessen in Kassel with two clinics with a total of 433 beds and an associated outpatient care center (MVZ), which generated sales of around €87 million in 2020. The DRK-Schwesternschaft remains a co-partner. Together with the existing Helios hospital in Warburg, a regional medical cluster shall be formed and expanded over the next few years. The acquisition is expected to be completed in the fourth quarter of 2021. The purchase price is 1 euro and includes the assumption of debts and the securing of liquidity for current operations and for future investments.

September 02, 2021Fresenius Helios
Fresenius Medical Care increases investment in Humacyte, accompanies human acellular vessel developer’s stock market launch

August 30, 2021Fresenius Medical Care

Brief News
Fresenius Medical Care opens new facility for laboratory services

Fresenius Medical Care North America opens a new laboratory in Mississippi, USA. With 200,000-square-foot (19,000 square-meters), it is the company’s largest facility of this kind. More than 300 jobs will be created over the next several years, providing the capacity to service more dialysis patients. At the new building, employees conduct comprehensive testing, analysis and reporting to ensure the best possible outcomes for patients.

August 19, 2021Fresenius Medical Care
Fresenius Medical Care uses virtual reality technology to train patients for home dialysis

August 04, 2021Fresenius Medical Care

Fresenius raises Group earnings guidance after very strong Q2

July 30, 2021Fresenius
Fresenius Medical Care reports results in line with expectations for the second quarter and confirms 2021 outlook

July 30, 2021Fresenius Medical Care

Fresenius signs 2 billion euros syndicated revolving credit facility with a link to sustainability

July 02, 2021Fresenius
Fresenius Medical Care signs 2 billion euros sustainability-linked syndicated revolving credit facility

July 02, 2021Fresenius Medical Care

Brief News
Fresenius Medical Care joins sustainability network econsense

Fresenius Medical Care has joined econsense, a network of German companies joined in the goal of shaping the transformation to a sustainable economy and society. The dialogue and cross-industry exchange of practical expertise within econsense, which now counts 40 major companies as members, will support Fresenius Medical Care’s sustainability management. Sustainability is an integral part of Fresenius Medical Care’s mission and vision and is also reflected in the corporate strategy. For the company, successful sustainability management means creating long-term economic, ecological and social value in order to provide patients with high-quality products and services while minimizing the impact of our activities on the environment.

July 01, 2021Fresenius Medical Care
Annual General Meeting: Fresenius remains on growth course despite pandemic; 28th consecutive dividend increase approved

May 21, 2021Fresenius

Study by Fresenius and Allensbach in three countries shows Germany lags in digitalization of medicine

May 21, 2021Fresenius

Disclaimer All news

Order Service News

Would you like to be included on our distribution list for media information? We would be happy to provide you with our latest press releases and brief news by e-mail. This service is free of charge and may be cancelled at any time.

Business & Finance

Medicine & Research

Brief News

German English

First name * Please enter your first name.

Last name * Please enter your lastname.

E-Mail Adress * Please enter your email-address.

Contact

Do you have other questions or need any more information?

Your contact:

Matthias Link

Senior Vice President Corporate Communications

T: +49 (0) 6172 608-2872
matthias.link@fresenius.com

Follow us

The Health Care Group

Contact us

Fresenius SE & Co. KGaA
Else-Kröner-Str. 1
61352 Bad Homburg v.d.H.
Germany
T +49 (0) 6172 608-0
pr-fre@fresenius.com

Contacts

Visit us